Concise Report
暂无分享,去创建一个
Tsutomu Takeuchi | Désirée van der Heijde | Maxime Dougados | João Eurico Fonseca | Patrick Durez | Tore K Kvien | Paul Emery | S. Eyre | A. Hinks | M. Dougados | M. D. de Wit | F. Breedveld | D. M. van der Heijde | P. Emery | E. Flynn | Paul Martin | G. Burmester | E. Martı́n-Mola | K. Pavelka | W. Graninger | J. Fonseca | J. Smolen | B. Haraoui | P. Durez | C. Codreanu | T. Kvien | J. Kalden | C. Montecucco | D. Aletaha | T. Takeuchi | M. Cardiel | E. Stanisławska-Biernat | I. Laurindo | A. Gibofsky | J. Gómez-Reino | Jane Worthington | Carlomaurizio Montecucco | Ferdinand C Breedveld | Daniel Aletaha | Josef S Smolen | V. Hamuryudan | Boulos Haraoui | Allan Gibofsky | Gerd Burmester | Catalin Codreanu | José Pereira Da Silva | Maarten de Wit | Juan Gomez-Reino | Winfried Graninger | Vedat Hamuryudan | Maria José Jannaut Peῆa | Joachim Kalden | Ieda Laurindo | Emilio Martin-Mola | Pedro Santos Moreno | Karel Pavelka | Gyula Poor | Mario H Cardiel | Ewa Stanislawska-Biernat | J. da Silva | G. Poór | P. Santos Moreno | A. Barton | W. Thomson | J. Packham
[1] C. Bombardier,et al. Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs , 2012, The Journal of Rheumatology.
[2] John Wong,et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs , 2010, Annals of the rheumatic diseases.
[3] D. Lackland,et al. Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. , 2003, Archives of internal medicine.
[4] B. Dijkmans,et al. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. , 2006, Clinical and experimental rheumatology.
[5] T. Pearson. The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease. , 2004, The American journal of cardiology.
[6] P. Tugwell,et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. , 2011, Arthritis and rheumatism.
[7] V. Bykerk,et al. Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population? , 2008, The Journal of rheumatology.
[8] P. Nilsson,et al. Glycemic and Risk Factor Control in Type 1 Diabetes , 2007, Diabetes Care.
[9] T. Pincus,et al. A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. , 2007, Best practice & research. Clinical rheumatology.
[10] M. Dougados,et al. Extended report: Evidence for treating rheumatoid arthritis to target: results of a systematic literature search , 2010 .
[11] A. McMahon,et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial , 2004, The Lancet.
[12] J. A. Rindfleisch,et al. Diagnosis and management of rheumatoid arthritis. , 2005, American family physician.
[13] M. Ravid,et al. Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study. , 2005, Journal of the American Society of Nephrology : JASN.
[14] Maurizio Cutolo,et al. Treating rheumatoid arthritis to target: recommendations of an international task force , 2010, Annals of the rheumatic diseases.